WASHINGTON--(BUSINESS WIRE)--The law firm of Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of ExactTarget, Inc. (NYSE: ET) (“ExactTarget” or “the Company”), concerning the proposed acquisition of the Company by salesforce.com, inc (NYSE:CRM). Under the terms of the agreement, salesforce.com, inc. expects to launch a cash tender offer for all outstanding shares of ExactTarget’s common stock, in which the Company’s shareholders would receive $33.75 per share. The transaction is valued at $2.5 billion. At least one analyst has set a target price of $39.00 for the Company’s shares.
The investigation is focused on the potential unfairness of the consideration to shareholders, the process by which the Company’s Board of Directors considered the transaction, as well as potential conflicts of interest among ExactTarget’s Board members.
If you are interested in discussing your rights as an ExactTarget shareholder, or have information relating to this investigation, please contact Finkelstein Thompson’s Washington, DC offices at (202)-337-8000 or by email at contact@finkelsteinthompson.com.
Finkelstein Thompson LLP has spent over three decades delivering outstanding representation to institutional and individual clients in financial litigation, and has been appointed as lead or co-counsel in dozens of shareholder class actions. Indeed, the firm has served in leadership roles in cases that have recovered over $1 billion for investors and consumers.
To learn more about Finkelstein Thompson LLP, please visit our website at www.finkelsteinthompson.com. Attorney advising. Prior results do not guarantee similar outcomes.
